ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Adaptyv Biosystems raised $40 million in Series A funding. The company will use the capital to advance its protein engineering platform. The funding round marks a significant investment in synthetic biology infrastructure.
Tap to vote and see what everyone thinks.
Summary by ByteBrief